These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20518197)

  • 21. Analysis of the efficacy and safety of sildenafil citrate in the geriatric population.
    Müller A; Smith L; Parker M; Mulhall JP
    BJU Int; 2007 Jul; 100(1):117-21. PubMed ID: 17552959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Erectile dysfunction and obstructive sleep apnea syndrome].
    Zhuravlev VN; Frank MA; Gomzhin AI
    Urologiia; 2008; (2):35, 37-9. PubMed ID: 18572768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen deficiency in the etiology and treatment of erectile dysfunction.
    Gore JL; Swerdloff RS; Rajfer J
    Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is sildenafil citrate associated with an amelioration of the symptomatology of androgen decline in the aging male?
    Koulikov D; Fridmans A; Chertin B; Shenfeld O; Farkas A; Spitz IM
    J Urol; 2007 Jun; 177(6):2267-71. PubMed ID: 17509338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].
    Bryniarski L; Rzepecki M; Klocek M; Wyczołkowski M
    Przegl Lek; 2009; 66(4):192-7. PubMed ID: 19708509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds.
    Wong P; Lawrentschuk N; Bolton DM
    Curr Opin Urol; 2009 Jan; 19(1):7-12. PubMed ID: 19057210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphodiesterase-5 inhibitors for lower urinary tract symptoms in men.
    Gales BJ; Gales MA
    Ann Pharmacother; 2008 Jan; 42(1):111-5. PubMed ID: 18094344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal supplementation and erectile dysfunction.
    Aversa A; Isidori AM; Greco EA; Giannetta E; Gianfrilli D; Spera E; Fabbri A
    Eur Urol; 2004 May; 45(5):535-8. PubMed ID: 15082192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erectile dysfunction in aging men: testosterone role in therapeutic protocols.
    Caretta N; Ferlin A; Palego PF; Foresta C
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):108-11. PubMed ID: 16760637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone.
    Garcia JA; Sanchez PE; Fraile C; Escovar P
    Andrologia; 2011 Oct; 43(5):293-6. PubMed ID: 21919947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging and sexual health: getting to the problem.
    Kaya E; Sikka SC; Kadowitz PJ; Gur S
    Aging Male; 2017 Jun; 20(2):65-80. PubMed ID: 28590829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
    Rosen RC; McKenna KE
    Annu Rev Sex Res; 2002; 13():36-88. PubMed ID: 12836729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism].
    Mazo EB; Gamidov SI; Sotnikova EM
    Ter Arkh; 2008; 80(12):59-63. PubMed ID: 19227909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk factors determine erectile and arterial function response to sildenafil.
    Solomon H; Wierzbicki AS; Lumb PJ; Lambert-Hammill M; Jackson G
    Am J Hypertens; 2006 Sep; 19(9):915-9. PubMed ID: 16942933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction.
    Park K; Ku JH; Kim SW; Paick JS
    BJU Int; 2005 Feb; 95(3):366-70. PubMed ID: 15679795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on adjunctive use of testosterone gel with sildenafil for erectile dysfunction.
    Morales A
    J Urol; 2008 May; 179(5 Suppl):S103. PubMed ID: 18405738
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone.
    Hwang TI; Chen HE; Tsai TF; Lin YC
    Int J Impot Res; 2006; 18(4):400-4. PubMed ID: 16395321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypogonadism and erectile dysfunction: the role for testosterone therapy.
    Shabsigh R
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S9-13. PubMed ID: 12934045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ageing men's sexual functions decline and the erectile dysfunction (ED) increase].
    Amar E; Grivel T; Hamidi K; Lemaire A; Giuliano F
    Prog Urol; 2005 Feb; 15(1):6-9. PubMed ID: 15822384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.